ZRSR2 Inhibitors

Chemical inhibitors of ZRSR2 target the splicing machinery of the cell, specifically the SF3b complex, which is crucial for the proper splicing of pre-mRNA into mature mRNA. Pladienolide B, E7107, Sudemycin D6, Meayamycin, Spliceostatin A, and H3B-8800 all exhibit a strong interaction with the SF3b complex. By binding to this complex, these compounds disrupt its normal function. The binding of Pladienolide B, for instance, leads to the disruption of spliceosome function, which is crucial for the RNA splicing activity where ZRSR2 plays a role. Similarly, E7107, a derivative of pladienolide, shares this mechanism of action, binding to the SF3b complex and inhibiting the splicing activity of ZRSR2. Sudemycin D6 and Meayamycin, on the other hand, target the SF3b complex more directly and interfere with its function, which is essential for ZRSR2's role in RNA splicing. Spliceostatin A interacts with the complex and impairs its function, leading to inhibited splicing activities involving ZRSR2. H3B-8800 preferentially binds to the SF3b complex, disrupting its function and thereby inhibiting ZRSR2's role in splicing.

Additional chemical inhibitors like FR901464, Madrasin, Tetrocarcin A, Herboxidiene, Isoginkgetin, and Placetin A also hinder the function of the SF3b complex and consequently ZRSR2's activity in RNA splicing. FR901464 targets the SF3b complex, inhibiting its function, which is critical for ZRSR2's role in splicing. Madrasin and Tetrocarcin A both bind to the SF3b complex and disrupt its function, thereby inhibiting ZRSR2's participation in RNA splicing. Herboxidiene, similar to the other inhibitors, targets the SF3b complex, resulting in inhibited splicing activities where ZRSR2 is involved. Isoginkgetin, a biflavonoid, indirectly inhibits splicing, affecting the spliceosome, which could disrupt ZRSR2's function in the splicing process. Lastly, Placetin A is known to interact with components of the spliceosome, thereby potentially inhibiting the function of ZRSR2 by impairing the splicing machinery. Each of these chemicals interacts with the SF3b complex or the spliceosome in a manner that disrupts ZRSR2's essential role in the RNA splicing process, leading to its functional inhibition.